Vera Fridman, MD

University of Colorado Anschutz Medical Campus and Hospital
Aurora, Colorado

Vera Fridman directs the CMTA Center of Excellence at the University of Colorado Hospital and her research to date has focused on paving the way for, and executing, treatment trials for neuropathy. She completed a longitudinal natural history study of CMT1A in the largest patient cohort reported to date in partnership with the Inherited Neuropathy Consortium Rare Disease Clinical Research Network. Together, they recently published a comprehensive review of demyelinating neuropathy mechanisms and treatments for a special issue of Neurotherapeutics.